Geode Capital Management, LLC Logic Bio Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$3.85 - $5.09 $24,424 - $32,290	6,344 Added 4.8%	138,465 $634,000
Q2 2021 Aug 13, 2021	SELL	$4.03 - $7.57 $392,094 - $736,515	-97,294 Reduced 42.41%	132,121 $586,000
Q1 2021 May 12, 2021	BUY	$6.8 - $9.16 $164,124 - $221,085	24,136 Added 11.76%	229,415 $1.67 Million
Q4 2020 Feb 12, 2021	BUY	$5.29 - $9.1 $366,263 - $630,056	69,237 Added 50.89%	205,279 $1.57 Million
Q3 2020 Nov 13, 2020	BUY	$5.41 - $9.45 $1,752 - $3,061	324 Added 0.24%	136,042 $1.24 Million
Q2 2020 Aug 13, 2020	BUY	$4.25 - $8.46 $140,925 - $280,525	33,159 Added 32.33%	135,718 $1.15 Million
Q1 2020 May 14, 2020	BUY	$4.06 - $11.0 $30,815 - $83,490	7,590 Added 7.99%	102,559 $506,000
Q4 2019 Feb 13, 2020	BUY	$7.01 - $11.01 $14,153 - $22,229	2,019 Added 2.17%	94,969 $683,000
Q3 2019 Nov 12, 2019	BUY	$6.97 - $13.46 $5,569 - $10,754	799 Added 0.87%	92,950 $1 Million
Q2 2019 Aug 14, 2019	BUY	$9.77 - $17.08 $286,436 - $500,751	29,318 Added 46.66%	92,151 $1.2 Million
Q1 2019 May 14, 2019	BUY	$7.93 - $10.41 $20,887 - $27,419	2,634 Added 4.38%	62,833 $620,000
Q4 2018 Feb 13, 2019	BUY	$7.88 - $17.98 $474,368 - $1.08 Million	60,199 New	60,199 $626,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.